Skip to content
  • Saturday, 15 August 2026
  • 12:25 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CNPV: A gamechanger for the pharma industry or simply more chaos?
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 19, 2026 0

The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 12, 2026 0

The United States Food and Drug Administration (FDA) embarked on a pivotal initiative in June 2025 with the announcement of…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 4, 2026 0

The United States Food and Drug Administration (FDA) embarked on a bold new initiative in June 2025 with the announcement…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jun 27, 2026 0

The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jun 20, 2026 0

The U.S. Food and Drug Administration (FDA) launched its Commissioner’s National Priority Voucher (CNPV) pilot program in June 2025, an…

Read More
Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer CachexiaIndiana University Researchers Identify IDOL Enzyme as Novel Therapeutic Target for Alzheimer’s Disease Treatment and NeuroprotectionCongruence secures $39.5m to advance small molecule correctors pipelineThe Elusive Identity of Borneo’s Fanged Frogs: Genetic Mysteries Challenge Species Definitions
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ